GWN Securities’s Evolus EOLS Stock Holding History

GWN Securities’s Portfolio EOLS Stock Details EOLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-48,913	Closed	-$325K	–	469
2025 Q4	$325K	Buy	+48,913	New	+$331K	0.07%	310

Other funds holding EOLS

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GWN Securities's EOLS Position: Q1 2026 in Review

GWN Securities sold out of Evolus (EOLS) in Q1 2026, closing a stake of 48,913 shares — an estimated $325K sold.

GWN Securities first reported a position in EOLS in Q4 2025 and held it in 1 quarter. The position peaked at $325K in Q4 2025. 147 funds tracked by Wall St. Rank hold EOLS as of Q1 2026.

GWN Securities reported no remaining Evolus position as of Q1 2026 after selling out during the quarter.
GWN Securities sold 48,913 Evolus shares in Q1 2026, an estimated $325K.
GWN Securities first reported a position in Evolus in Q4 2025 and held it in 1 quarter.
GWN Securities's Evolus position peaked at $325K in Q4 2025.
147 funds tracked by Wall St. Rank held Evolus as of Q1 2026.

Based on GWN Securities's 13F filing for Q1 2026, filed 15 May 2026.